Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Uveal Melanoma · Metastatic Uveal Melanoma in the Liver

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Miami, Miami, Florida, United States
Contact: Study coordinator (Lynn Feun, MD) · lfeun@med.miami.edu · (305) 243-4981
Contact: Study coordinator (Benjamin Spieler, MD) · bspieler@med.miami.edu · (305) 243-4229
Contact: Principal Investigator (Lynn Feun, MD)
Contact: Principal Investigator (Benjamin Spieler, MD)

Study leads

Lynn Feun, MD
Principal Investigator
University of Miami

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tebentafusp-tebn With LDT in Metastatic UM

Metastatic Uveal Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Philadelphia, United States

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Metastatic Uveal Melanoma

Abroad (travel likely)RecruitingPHASE2

Tampa, United States

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Uveal Melanoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

Adjuvant Tebentafusp in High Risk Ocular Melanoma

Uveal Melanoma

Abroad (travel likely)RecruitingPHASE3

Lake Success, United States · Brussels, Belgium